NFC-Enabled Medication Packaging for Secure Patient Data Exchange
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Pharmaceutical companies face challenges in establishing secure and effective communication with patients due to the lack of efficient communication channels, particularly for providing personalized medication information, adherence guidance, and collecting feedback, while ensuring privacy and security, especially with existing NFC technologies being static and non-programmable.
Innovation Solution
A near-field communication (NFC)-enabled medication packaging system that incorporates a writable NFC tag initialized with medication data, allowing for secure communication between the patient's device and the pharmaceutical company's server, enabling personalized guidance and feedback through a secure channel, using public and private key encryption for authentication and data protection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of information
If traditional printed information (barcode, QR codes) is used for smart labels, then basic information can be displayed to patients, but interaction with the pharmaceutical company is not possible
Solution Approach 1:
The patent replaces traditional mechanical printed information systems (barcodes, QR codes) with NFC (Near Field Communication) technology, enabling bidirectional wireless communication between the medication package and the patient's mobile device, thereby enabling interaction capabilities while maintaining information delivery
Solution Approach 2:
The patent introduces an NFC tag as an intermediary component embedded in the medication package, which serves as a bridge between the physical medication and the digital communication system, allowing patients to interact with the pharmaceutical company through their mobile devices
2Loss of information
If NFC tags are used for medication packaging, then patient data can be accessed, but the tags are not writable and information is static rather than personalized
Solution Approach 1:
The patent implements a dynamic NFC tag system that can be written to and updated, allowing the information to change from static manufacturer data to dynamic personalized patient information including adherence tracking, personalized messages, and real-time feedback capabilities
Solution Approach 2:
The patent pre-provisions the NFC tag with basic manufacturer information and authentication credentials during manufacturing, then enables subsequent writing of personalized patient data at the point of care or through initial patient setup
3Reliability
If secure communication channels are established between pharmaceutical companies and patients, then privacy and security are ensured, but communication complexity increases
Solution Approach 1:
The patent uses the NFC tag and mobile device application as intermediaries that handle complex encryption and authentication protocols, shielding patients from complexity while maintaining high security standards through established cryptographic methods
Solution Approach 2:
The patent implements automated authentication and encryption processes that occur transparently in the background without requiring patient intervention, with the system automatically managing key exchange and secure connection establishment
4Adaptability or versatility
If writable NFC tags are implemented in medication packaging, then personalized and dynamic information can be provided, but cost and manufacturing complexity increase
Solution Approach 1:
The patent provisions basic NFC tag functionality and authentication data during standard packaging manufacturing processes, then enables selective writing of personalized information only when needed, minimizing impact on base manufacturing while adding capability where required
Solution Approach 2:
The patent designs the NFC tag system to serve multiple functions including authentication, information delivery, adherence tracking, and two-way communication, consolidating what would otherwise require multiple separate components into a single universal platform
Data Source
AI summary
A system and method to establish a no-login authenticated and contextualized two-ways data flow between a medicine user and the pharmaceutical manufacturer. Near Field Communication (NFC) technology, enabling short-range communication between two compatible devices is utilized via a writeable NFC tag carried by a medication package. The writeable NFC tag includes medication information, anti-counterfeiting information, as well as data about the patient and the prescription. The NFC tag may be read by a user device associated with the patient, enabling the user device to merge this data with the patient's feedback, send this rich flow in a secure way to the manufacturer, who in turn is now able to provide rich contextual guidance to the patient.